Drug intelligence / Profile preview

huganning jiaonang

Development stage: Unknown
Lead developer: Beijing Yushengtang
Administration: Oral

Overview

Huganning Jiaonang is a traditional Chinese medicine (TCM) oral capsule developed and manufactured by Beijing Yushengtang Pharmaceutical. It is an approved pharmaceutical product in China indicated for the treatment of acute and chronic hepatitis, particularly those presenting with damp-heat symptoms in the liver and gallbladder. The formulation is composed of several herbal extracts, including *Artemisiae Scopariae Herba*, *Polygoni Cuspidati Rhizoma et Radix*, and *Salviae Miltiorrhizae Radix et Rhizoma*, which work synergistically to clear heat, detoxify the liver, and promote bile flow. Clinically, it is used to reduce elevated liver enzymes (transaminases) and alleviate symptoms such as jaundice, hypochondriac pain, and fatigue.

Brand names: 护肝宁胶囊
Other names: Huganning capsule

Beyond the preview

Go deeper on huganning jiaonang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on huganning jiaonang.

Explore the full profile